Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Ready to take your transformation to the next level
At 40 weeks, all three doses (3 mg, 12 mg, 36 mg) of orforglipron achieved the primary endpoint of superior A1C reduction compared to placebo , lowering A1C by 1.3% to 1.6% from a baseline of 8.0% , with improvements seen as early as 4 weeks
But the drugs have also been a lifeline for hundreds of thousands of Medi-Cal patients with obesity, who could now regress on their weight-loss
doi:10.1074/jbc.M109.033829
US$ 21.64
US$ 23.85
US$ 22.62
US$ 23.75
